Eli Lilly (LLY) Non Operating Income (2009 - 2026)
Eli Lilly posted quarterly Non Operating Income of -$65.0 million for Q1 2026, up 72.8% year-on-year from -$37.6 million in Q1 2025, and up 39.98% on a QoQ basis from -$108.3 million in Q4 2025.
Eli Lilly (LLY) has 18 years of Non Operating Income data on file, last reported at -$65.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 72.8% year-over-year to -$65.0 million; the trailing twelve-month figure through Mar 2026 stood at -$397.0 million (up 18.16% YoY), and the FY2025 full-year result was -$571.0 million, down 160.73% from the prior year.
- Non Operating Income for Q1 2026 stood at -$65.0 million, up from -$108.3 million in the prior quarter.
- Across five years, Non Operating Income topped out at $260.0 million in Q4 2022 and bottomed at -$350.7 million in Q1 2022.
- The 5-year median for Non Operating Income is -$90.6 million (2025), against an average of -$63.5 million.
- The widest annual swing landed in 2022, when Non Operating Income soared 436.35%; it then plunged 981.92% in 2025.
- A 5-year view of Non Operating Income shows it stood at $260.0 million in 2022, then plunged by 53.35% to $121.3 million in 2023, then tumbled by 191.1% to -$110.5 million in 2024, then gained by 1.99% to -$108.3 million in 2025, then jumped by 39.98% to -$65.0 million in 2026.
- The last three Non Operating Income figures came in at -$65.0 million (Q1 2026), -$108.3 million (Q4 2025), and -$133.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -65.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -294.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -2.31 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -138.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 235.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -861.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -32.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.00 Mn |
| Dec 31, 2025 | -108.30 Mn |
| Sep 30, 2025 | -133.10 Mn |
| Jun 30, 2025 | -90.60 Mn |
| Mar 31, 2025 | -239.00 Mn |
| Dec 31, 2024 | -110.50 Mn |
| Sep 30, 2024 | 62.00 Mn |
| Jun 30, 2024 | -197.60 Mn |
| Mar 31, 2024 | 27.10 Mn |
| Dec 31, 2023 | 121.30 Mn |
| Sep 30, 2023 | -23.20 Mn |
| Jun 30, 2023 | -36.80 Mn |
| Mar 31, 2023 | 35.70 Mn |
| Dec 31, 2022 | 260.00 Mn |
| Sep 30, 2022 | -111.00 Mn |
| Jun 30, 2022 | -119.20 Mn |
| Mar 31, 2022 | -350.70 Mn |
| Dec 31, 2021 | -77.30 Mn |
| Sep 30, 2021 | -635.90 Mn |
| Jun 30, 2021 | 190.50 Mn |
| Mar 31, 2021 | 321.10 Mn |
| Dec 31, 2020 | 477.00 Mn |
| Sep 30, 2020 | 158.90 Mn |
| Jun 30, 2020 | 446.90 Mn |
| Mar 31, 2020 | 89.10 Mn |
| Dec 31, 2019 | 262.90 Mn |
| Sep 30, 2019 | -24.90 Mn |
| Jun 30, 2019 | -32.40 Mn |
| Mar 31, 2019 | 86.00 Mn |
| Dec 31, 2018 | 31.40 Mn |
| Sep 30, 2018 | -1.90 Mn |
| Jun 30, 2018 | 46.60 Mn |
| Mar 31, 2018 | 69.50 Mn |
| Dec 31, 2017 | 112.90 Mn |
| Sep 30, 2017 | 49.90 Mn |
| Jun 30, 2017 | 60.40 Mn |
| Mar 31, 2017 | 78.30 Mn |
| Dec 31, 2016 | 15.80 Mn |
| Sep 30, 2016 | 27.20 Mn |
| Jun 30, 2016 | 21.20 Mn |
| Mar 31, 2016 | -149.00 Mn |
| Dec 31, 2015 | 44.70 Mn |
| Sep 30, 2015 | 86.50 Mn |
| Jun 30, 2015 | -123.30 Mn |
| Mar 31, 2015 | 92.70 Mn |
| Dec 31, 2014 | 137.20 Mn |
| Sep 30, 2014 | 93.50 Mn |
| Jun 30, 2014 | 53.80 Mn |
| Mar 31, 2014 | 56.00 Mn |
| Dec 31, 2013 | 9.10 Mn |
| Sep 30, 2013 | -31.30 Mn |
| Jun 30, 2013 | 11.90 Mn |
| Mar 31, 2013 | 529.20 Mn |
| Dec 31, 2012 | -52.00 Mn |
| Sep 30, 2012 | 788.50 Mn |
| Jun 30, 2012 | -16.50 Mn |
| Mar 31, 2012 | -46.00 Mn |
| Dec 31, 2011 | -26.80 Mn |
| Sep 30, 2011 | -83.40 Mn |
| Jun 30, 2011 | -57.60 Mn |
| Mar 31, 2011 | -11.20 Mn |
| Dec 31, 2010 | -143.80 Mn |
| Sep 30, 2010 | 9.20 Mn |
| Jun 30, 2010 | -18.40 Mn |
| Mar 31, 2010 | 111.50 Mn |
| Dec 31, 2009 | -391.20 Mn |
| Sep 30, 2009 | 66.90 Mn |
| Jun 30, 2009 | -24.10 Mn |
| Mar 31, 2009 | -70.70 Mn |